80.3%
atezolizumabpaclitaxelClavien Dindo 3AifosfamidenimotuzumabcisplatinPatent bluetoripalimabICGTc nanocolloid+3 more
…poor. The PERICLES study explored a novel strategy of combining atezolizumab with radiation therapy for patients with advanced PeCa. 65 Howe…